Retatrutide's position will most likely mirror how tirzepatide is utilised currently: as the subsequent-line choice for sufferers who plateau on solitary-agonist GLP-1 therapy or who require the extra metabolic benefits that glucagon agonism provides (hepatic fat reduction, lean mass preservation, i